Perform Another (Advanced) Search

1.  CenterWatch: Clinical Trials in Category (834) Pain
...Bludesch : Research Site: A Study of Intravenous Bondronat (Ibandronate) in Patients With Breast Cancer and Bone Metastasis Graz : Research Site: A Study of Intravenous Bondronat (Ibandronate) in Patients With Breast Cancer and ...
View Page

2.  Study Posting (4166) Trial #95566, Prostate Cancer, Tallahassee, FL
...Prostate Cancer, Tallahassee, FL Trial Information A Phase III Study of Study Drug on Prolonging Bone Metastasis-Free Survival in Men with Hormone- Refractory Prostate Cancer This study is designed to investigate ...
View Page

3.  Study Posting (2022) Trial #162618, Prostate Cancer, Albuquerque, NM
...Study Posting (2022) Trial #162618, Prostate Cancer, Albuquerque, NM Trial Information Prostate Cancer with/without bone metastasis We are currently recruiting patients for the following: • Studies to treat men with Prostate Cancer ...
View Page

4.  Study Posting (1768) Trial #108861, Prostate Cancer, Staten Island, NY
...A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Phase 3 Study of Denosumab on Prolonging Bone Metastasis-Free Survival in Men with Hormone Refractory Prostate Cancer Is your PSA rising despite hormone ...
View Page

5.  Study Posting (4519) Trial #152178, Pain, St Gallen, Switzerland
...Switzerland Trial Information A Study of Intravenous Bondronat (Ibandronate) in Patients With Breast Cancer and Bone Metastasis Status: Completed Protocol Number: ML17632 Sponsor: Roche Pharma (Switzerland) AG Company Division: Pharmaceutical Official Scientific ...
View Page

6.  Study Posting (4519) Trial #152176, Pain, St Gallen, Switzerland
...Switzerland Trial Information A Study of Intravenous Bondronat (Ibandronate) in Patients With Breast Cancer and Bone Metastasis Status: Completed Protocol Number: ML17632 Sponsor: Roche Pharma (Switzerland) AG Company Division: Pharmaceutical Official Scientific ...
View Page

7.  Study Posting (4519) Trial #151997, Pain, Nyon, Switzerland
...Switzerland Trial Information A Study of Intravenous Bondronat (Ibandronate) in Patients With Breast Cancer and Bone Metastasis Status: Completed Protocol Number: ML17632 Sponsor: Roche Pharma (Switzerland) AG Company Division: Pharmaceutical Official Scientific ...
View Page

8.  Study Posting (4519) Trial #151995, Pain, Nyon, Switzerland
...Switzerland Trial Information A Study of Intravenous Bondronat (Ibandronate) in Patients With Breast Cancer and Bone Metastasis Status: Completed Protocol Number: ML17632 Sponsor: Roche Pharma (Switzerland) AG Company Division: Pharmaceutical Official Scientific ...
View Page

9.  Study Posting (4519) Trial #151959, Pain, Neuchatel, Switzerland
...Switzerland Trial Information A Study of Intravenous Bondronat (Ibandronate) in Patients With Breast Cancer and Bone Metastasis Status: Completed Protocol Number: ML17632 Sponsor: Roche Pharma (Switzerland) AG Company Division: Pharmaceutical Official Scientific ...
View Page

10.  Study Posting (4519) Trial #151957, Pain, Neuchatel, Switzerland
...Switzerland Trial Information A Study of Intravenous Bondronat (Ibandronate) in Patients With Breast Cancer and Bone Metastasis Status: Completed Protocol Number: ML17632 Sponsor: Roche Pharma (Switzerland) AG Company Division: Pharmaceutical Official Scientific ...
View Page

11.  Study Posting (4519) Trial #151818, Pain, Lugano, Switzerland
...Switzerland Trial Information A Study of Intravenous Bondronat (Ibandronate) in Patients With Breast Cancer and Bone Metastasis Status: Completed Protocol Number: ML17632 Sponsor: Roche Pharma (Switzerland) AG Company Division: Pharmaceutical Official Scientific ...
View Page

12.  Study Posting (4519) Trial #151816, Pain, Lugano, Switzerland
...Switzerland Trial Information A Study of Intravenous Bondronat (Ibandronate) in Patients With Breast Cancer and Bone Metastasis Status: Completed Protocol Number: ML17632 Sponsor: Roche Pharma (Switzerland) AG Company Division: Pharmaceutical Official Scientific ...
View Page

13.  Study Posting (4519) Trial #151971, Pain, Locarno, Switzerland
...Switzerland Trial Information A Study of Intravenous Bondronat (Ibandronate) in Patients With Breast Cancer and Bone Metastasis Status: Completed Protocol Number: ML17632 Sponsor: Roche Pharma (Switzerland) AG Company Division: Pharmaceutical Official Scientific ...
View Page

14.  Study Posting (4519) Trial #151969, Pain, Locarno, Switzerland
...Switzerland Trial Information A Study of Intravenous Bondronat (Ibandronate) in Patients With Breast Cancer and Bone Metastasis Status: Completed Protocol Number: ML17632 Sponsor: Roche Pharma (Switzerland) AG Company Division: Pharmaceutical Official Scientific ...
View Page

15.  Study Posting (4519) Trial #151932, Pain, Genolier, Switzerland
...Switzerland Trial Information A Study of Intravenous Bondronat (Ibandronate) in Patients With Breast Cancer and Bone Metastasis Status: Completed Protocol Number: ML17632 Sponsor: Roche Pharma (Switzerland) AG Company Division: Pharmaceutical Official Scientific ...
View Page

16.  Study Posting (4519) Trial #151930, Pain, Genolier, Switzerland
...Switzerland Trial Information A Study of Intravenous Bondronat (Ibandronate) in Patients With Breast Cancer and Bone Metastasis Status: Completed Protocol Number: ML17632 Sponsor: Roche Pharma (Switzerland) AG Company Division: Pharmaceutical Official Scientific ...
View Page

17.  Study Posting (4519) Trial #152059, Pain, Geneve, Switzerland
...Switzerland Trial Information A Study of Intravenous Bondronat (Ibandronate) in Patients With Breast Cancer and Bone Metastasis Status: Completed Protocol Number: ML17632 Sponsor: Roche Pharma (Switzerland) AG Company Division: Pharmaceutical Official Scientific ...
View Page

18.  Study Posting (4519) Trial #152057, Pain, Geneve, Switzerland
...Switzerland Trial Information A Study of Intravenous Bondronat (Ibandronate) in Patients With Breast Cancer and Bone Metastasis Status: Completed Protocol Number: ML17632 Sponsor: Roche Pharma (Switzerland) AG Company Division: Pharmaceutical Official Scientific ...
View Page

19.  Study Posting (4519) Trial #151672, Pain, Chur, Switzerland
...Switzerland Trial Information A Study of Intravenous Bondronat (Ibandronate) in Patients With Breast Cancer and Bone Metastasis Status: Completed Protocol Number: ML17632 Sponsor: Roche Pharma (Switzerland) AG Company Division: Pharmaceutical Official Scientific ...
View Page

20.  Study Posting (4519) Trial #151670, Pain, Chur, Switzerland
...Switzerland Trial Information A Study of Intravenous Bondronat (Ibandronate) in Patients With Breast Cancer and Bone Metastasis Status: Completed Protocol Number: ML17632 Sponsor: Roche Pharma (Switzerland) AG Company Division: Pharmaceutical Official Scientific ...
View Page